Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Apr 9, 2008

Investigators Uncover Protein Involved in Chronic HBV Infection

  • Scientists from University College London identified a key difference between people who can fight HBV off successfully and those who can’t. The researchers screened more than 5,000 genes in T cells from both recovered and chronically infected HBV patients.

    They found that in the latter group, a proapoptotic protein found in T cells called Bim was overexpressed. Furthermore, blocking the protein induced“recovery of HBV-specific CD8+ T cells both in culture and directly ex vivo,” the investigators write.

    Their findings are published in the April 9 issue of the Journal of Clinical Investigation.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »